April 12, 2022 RDCA-DAP Responsive Curation Levels – Dr. Ramona Walls This was presented as part of the RDCA-DAP monthly steering committee meeting, on April 12, 2022. It describes the 8 curation...
C-Path to Lead Novel Pre-Consortium Framework for Optimizing the Rare and Orphan Medical Product Lifecycle TUCSON, Ariz., April 28, 2022 — Critical Path Institute (C-Path), in collaboration with one of the industry’s prominent r
April 26, 2022 C-Path in Europe: Moving Global Regulatory Science Forward Critical Path Institute is a catalyst for innovation that accelerates the path to a healthier world...
June 15, 2022 View Now | Using Ontologies to Standardize Rare Disease Data Collection presented by Monarch Initiative This webinar will provide an overview of biomedical ontologies and demonstrate how they can be used for standardizing and integrat
May 18, 2022 View Now: Generating Synthetic Longitudinal Data presented by Replica Analytics In this webinar, Replica Analytics’ Dr. Khaled El Emam is joined by Director of Data Science Lucy Mosquera to provide a gene
April 22, 2022 Perceptions of Parents, Nurses and Physicians Regarding Research Communication in the NICU: Results of an International Survey
May 23, 2022-February 8, 2024 View Now | International 2022 Drug-induced Kidney Injury Biomarker Workshop On May 23-24 the International Drug-induced Kidney Injury Biomarker Workshop will be held in a virtual format. Critical Path Insti
Longtime Pharmaceutical Executive to Lead C-Path’s Sickle Cell Disease Consortium TUCSON, Ariz., April 14, 2022 – Critical Path Institute (C-Path) has named Sergey Rakhilin, Ph.D., as Executive Director of its
April 11, 2022 Quantitative System Pharmacology as a Legitimate Approach to Examine Extrapolation Strategies used to Support Pediatric Drug Development; Azer K, Barrett JS
April 11, 2022 Role of Disease Progression Models in Drug Development. Pharmaceutical Research; Jeffrey S Barrett, Tim Nicholas, Karim Azer, Brian W Corrigan